Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Alzheimer's Drug ARIA Monitoring: Real-World Study Results

(MedPage Today) -- Rates of amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease patients treated with lecanemab (Leqembi) in the real world were consistent with those seen in clinical trials, data from the LEADER study showed....

Alzheimer's Drug ARIA Monitoring: Real-World Study Results

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 15 October →